medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2021, Number 3

<< Back Next >>

Rev Nefrol Dial Traspl 2021; 41 (3)

Sarcopenia, peripheral neuropathy, and peripheral arterial disease in patients with diabetes mellitus under hemodialysis

Bustamante HMB, Garduño GJJ, Montenegro MLP, Camarillo RES, Huitrón BG, Camarillo RMS

Language: Spanish
References: 36
Page: 151-158
PDF size: 141.27 Kb.


ABSTRACT

Introduction: Sarcopenia is characterized by loss of strength and muscle mass. Patients with diabetes mellitus who are under hemodialysis treatment show decreased physical activity and changes in their food intake, which also leads to the presence of sarcopenia. On the other hand, peripheral neuropathy and peripheral arterial disease commonly appear as chronic complications of diabetes mellitus. Methods: A cross-sectional, observational study was carried out in diabetes mellitus patients on hemodialysis. For the assessment of sarcopenia, muscle strength, physical performance and muscle mass percentage were measured. Muscle strength was calculated with a dynamometer, while physical performance was evaluated in seconds by means of a walk test with a stopwatch; muscle mass percentage was obtained using a scale with bioelectrical impedance. Sarcopenia was considered severe when there was low muscle strength and percentage in addition to low physical performance. Peripheral neuropathy was assessed by exploring touch and pressure sensibility with the Semmes-Weinstein monofilament test and deep sensibility with a 128 Hz tuning fork. The ankle-brachial index was the measurement taken for the peripheral arterial disease classification. Results: The final analysis was performed with 33 patients, whose time on hemodialysis was 3.57 ± 2.56 years. The prevalence of severe sarcopenia and sarcopenia was 90.8% and that of pre-sarcopenia was 9% of all patients. On the other hand, 78.1% were found to be patients with loss of deep sensibility, while the percentage of patients with loss of sensibility to pressure and touch was 54.5%. A correlation was found between the sarcopenia parameters and the time of evolution of renal failure and age. Conclusion: Sarcopenia occurs, in its different stages, in practically all diabetes mellitus patients undergoing hemodialysis; there is a relationship with the patient’s age and hemodialysis time.


REFERENCES

  1. Baumgartner RN, Koehler KM, Gallagher D, RomeroL, Heymsfield SB, Ross RR, et al. Epidemiology ofsarcopenia among the elderly in New Mexico. AmJ Epidemiol. 1998;147(8):755-63. doi: 10.1093/oxfordjournals.aje.a009520.

  2. Dent E, Morley JE, Cruz-Jentoft AJ, Arai H,Kritchevsky SB, Guralnik J, et al. International ClinicalPractice Guidelines for Sarcopenia (ICFSR): screening,Diagnosis and Management. J Nutr Health Aging.2018;22(10):1148-61. doi: 10.1007/s12603-018-1139-9.

  3. Sakuma K, Aoi W, Yamaguchi A. Current understandingof sarcopenia: possible candidates modulating musclemass. Pflugers Arch. 2015;467(2):213-29. doi: 10.1007/s00424-014-1527-x.

  4. Kittiskulnam P, Carrero JJ, Chertow GM, KaysenGA, Delgado C, Johansen KL. Sarcopenia amongpatients receiving hemodialysis: weighing the evidence.J Cachexia Sarcopenia Muscle. 2017;8(1):57-68. doi:10.1002/jcsm.12130.

  5. Cusumano AM. Sarcopenia en pacientes con y sininsuficiencia renal crónica: diagnóstico, evaluación ytratamiento. Rev Nefrol Dial Traspl. 2015;35(1):32-3.

  6. Veronese N, Pizzol D, Demurtas J, Soysal P, SmithL, Sieber C, et al. Association between sarcopeniaand diabetes: a systematic review and meta-analysis ofobservational studies. Eur Geriatr Med. 2019;10(5):685-96. doi: 10.1007/s41999-019-00216-x.

  7. Kim YK, Lee HS, Ryu JJ, In Lee H, Seo SG. Sarcopeniaincreases the risk for mortality in patients whoundergo amputation for diabetic foot. J Foot Ankle Res.2018;11:32. doi: 10.1186/s13047-018-0274-1.

  8. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, BruyèreO, Cederholm T, et al.; Writing Group for theEuropean Working Group on Sarcopenia in OlderPeople 2 (EWGSOP2), and the Extended Group forEWGSOP2. Sarcopenia: revised European consensuson definition and diagnosis. Age Ageing. 2019;48(1):16-31. doi: 10.1093/ageing/afy169.

  9. Dive D, Lievens I, Moonen G, Wang FC. Laneuropathie diabétique périphérique [Diabeticperipheral neuropathy]. Rev Med Liege. 2005;60(5-6):490-7.

  10. Alba Zayas LE, Pereira Roca G, Aguilar BetancourtA. Lipoproteína (a): estructura, metabolismo, genéticay mecanismos patogénicos. Rev Cubana Invest Bioméd.2003;22(1):32-40.

  11. Triana Ricci R. Pie diabético. Fisiopatología yconsecuencias. Nefrología (Madr.). 2014;28(4):143-53.doi: 10.1016/j.rccot.2015.04.006.

  12. Asociación Latinoamericana de Diabetes. GuíasALAD sobre el diagnóstico, control y tratamiento dela diabetes mellitus tipo 2 con medicina basada enevidencia. Rev ALAD. 2019;(9 Supl. 1):1-119.

  13. Escobar C, Barrios V, Manzano L. Relevancia dela enfermedad arterial periférica en sujetos de edadavanzada. Hipertens Riesgo Vasc. 2012;29(1):14-21. doi:10.1016/j.hipert.2011.12.001.

  14. Serrano Hernando FJ, Martín Conejero A. Enfermedadarterial periférica: aspectos fisiopatológicos, clínicos yterapéuticos. Rev Esp Cardiol. 2007;60(9):969-82. doi:10.1157/13109651.

  15. Adam DJ, Bradbury AW. TASC II Document onthe Management of Peripheral Arterial Disease. Eur JVasc Endovasc Surg. 2007;33(1):1-2). doi: 10.1016/j.ejvs.2006.11.008.

  16. Lechuga Domínguez MJ, Rodríguez García A, VázquezCaridad EM. Análisis de los factores influyentes enla prevalencia de las úlceras de pie en pacientes enhemodiálisis. Enferm Nefrol. 2017;20(2):101-11. doi:10.4321/s2254-288420170000200002.

  17. Schaper NC, van Netten JJ, Apelqvist E, Sicco A,Hinchliffe RJ, Lipsky BA. Directrices IWGDF enla prevención y tratamiento de la enfermedad del piediabético [Internet]. Bruselas: International WorkingGroup on the Diabetic Foot, 2019. 194 p. Disponibleen: (consulta: 23-07-2020).

  18. Sousa-Santos AR, Amaral TF. Differences in handgripstrength protocols to identify sarcopenia and frailty - asystematic review. BMC Geriatr. 2017;17(1):238. doi:10.1186/s12877-017-0625-y.

  19. Abro A, Delicata LA, Vongsanim S, DavenportA. Differences in the prevalence of sarcopenia inperitoneal dialysis patients using hand grip strengthand appendicular lean mass: depends upon guidelinedefinitions. Eur J Clin Nutr. 2018;72(7):993-999. doi:10.1038/s41430-018-0238-3.

  20. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, BruyèreO, Cederholm T, et al. Writing Group for theEuropean Working Group on Sarcopenia in OlderPeople 2 (EWGSOP2), and the Extended Group forEWGSOP2. Sarcopenia: revised European consensuson definition and diagnosis. Age Ageing. 2019;48(1):16-31. doi: 10.1093/ageing/afy169.

  21. Mori K, Nishide K, Okuno S, Shoji T, Emoto M,Tsuda A, et al. Impact of diabetes on sarcopenia andmortality in patients undergoing hemodialysis. BMCNephrol. 2019;20(1):105. doi: 10.1186/s12882-019-1271-8.

  22. Mesinovic J, Zengin A, De Courten B, Ebeling PR,Scott D. Sarcopenia and type 2 diabetes mellitus: abidirectional relationship. Diabetes Metab Syndr Obes.2019;12:1057-72. doi: 10.2147/DMSO.S186600.

  23. Yasemin Ö, Seydahmet A, Özcan K. Relationshipbetween diabetic neuropathy and sarcopenia. PrimCare Diabetes. 2019;13(6):521-8. doi: 10.1016/j.pcd.2019.04.007.

  24. Kittiskulnam P, Chertow GM, Carrero JJ, Delgado C,Kaysen GA, Johansen KL. Sarcopenia and its individualcriteria are associated, in part, with mortality amongpatients on hemodialysis. Kidney Int. 2017;92(1):238-47. doi: 10.1016/j.kint.2017.01.024.

  25. Harada H, Ikeda H, Nishiyama Y, Niiyama H,Katoh A, Kai H. Increased arterial velocity pulseindex is an independent factor related to skeletalmuscle mass reduction and tissue damage in patientswith cardiovascular disease. Hypertension Res.2020;43(6):534-42. doi: 10.1038/s41440-020-0404-6.

  26. Oh TJ, Kang S, Lee JE, Moon JH, Choi SH, LimS, et al. Association between deterioration in musclestrength and peripheral neuropathy in people withdiabetes. J Diabetes Complications. 2019;33(8):598-601. doi: 10.1016/j.jdiacomp.2019.04.007.

  27. Tian SL, Zhang K, Xu PC. Increased prevalenceof peripheral arterial disease in patients with obesesarcopenia undergoing hemodialysis. Exp Ther Med.2018;15(6):5148-52. doi: 10.3892/etm.2018.6002.

  28. Lera L, Ángel B, Sánchez H, Picrin Y, HormazabalMJ, Quiero A, et al. Estimación y validación de puntosde corte de índice de masa muscular esquelética parala identificación de sarcopenia en adultos mayoreschilenos. Nutr Hosp. 2015;31(3):1187-97. doi:10.3305/nh.2015.31.3.8054.

  29. Villada-Gómez JS, González-Correa CH, Marulanda-Mejía F. Puntos de corte provisionales para eldiagnóstico de sarcopenia en ancianos de Caldas,Colombia. Biomédica. 2018;38(4):521-6. doi: doi:10.7705/biomedica.v38i4.4302.

  30. Chen LK, Liu LK, Woo J, Assantachai P, AuyeungTW, Bahyah KS, et al. Sarcopenia in Asia: consensusreport of the Asian Working Group for Sarcopenia. JAm Med Dir Assoc. 2014;15(2):95-101. doi: 10.1016/j.jamda.2013.11.025.

  31. Yang Q, Zhang Y, Zeng Q, Yang C, Shi J, Zhang C, etal. Correlation between diabetic peripheral neuropathyand sarcopenia in patients with type 2 diabetes mellitusand diabetic foot disease: a cross-sectional study.Diabetes Metab Syndr Obes. 2020;13:377-86. doi:10.2147/DMSO.S237362.

  32. Tavakoli M, Gogas Yavuz D, Tahrani AA, SelvarajahD, Bowling FL, Fadavi H. Diabetic neuropathy:current status and future prospects. J Diabetes Res.2017;2017:5825971. doi: 10.1155/2017/5825971.

  33. Beckert S, Sundermann K, Wolf S, Königsrainer A,Coerper S. Haemodialysis is associated with changesin cutaneous microcirculation in diabetes mellitus.Diabet Med. 2009;26(1):89-92. doi: 10.1111/j.1464-5491.2008.02610.x.

  34. Castro-Sánchez AM, Moreno-Lorenzo C, Matarán-Peñarrocha GA, Feriche-Fernández-Castanys B,Sánchez Labraca N, et al. Eficacia de un programade masaje y ejercicio sobre el índice tobillo/brazo ypresión sanguínea en pacientes con diabetes mellitustipo 2 y enfermedad arterial periférica: ensayo clínicoaleatorizado. Med Clin (Barc). 2010;134(3):107-10.doi: 10.1016/j.medcli.2009.07.018.

  35. Sheng K, Zhang P, Chen L, Cheng J, Wu C, ChenJ. Intradialytic exercise in hemodialysis patients: asystematic review and meta-analysis. Am J Nephrol.2014;40(5):478-90. doi: 10.1159/000368722.

  36. Qiu Z, Zheng K, Zhang H, Feng J, Wang L, Zhou H.Physical exercise and patients with chronic renal failure:a meta-analysis. Biomed Res Int. 2017;2017:7191826.doi: 10.1155/2017/7191826.




2020     |     www.medigraphic.com